Simultaneous Ligand-Directed Cytotoxic Toxin and Endosome Disruptor Delivery to Ablate Prostate Cancer
Abstract
In this grant we proposed to develop toxins that targeted GnRH-R and endosome disruptors that targeted bombesin 2 receptors to treat prostate cancer. In this first year, we have made GnRH-Gelonin and GnRH-Saporin conjugates. We have also established that GnRH-Gelonin and GnRH-Saporin conjugates induce apoptosis in a metastatic human prostate cancer cell lines(PC-3). We have further shown that targeting the endosome disruptor, listeriolysin O (LLO),to PC-3 cells using the kisspeptin receptor agonist (metastin) induces apoptosis. Metastin targeted LLO increases apoptosis induced by GnRH-Gelonin and/or GnRH-Saporin conjugates. We have developed a 2-step FPLC based purification for a his-tagged LLO that includes hydrophobic interaction chromatography followed by nickel affinity chromatography.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2018
- Accession Number
- AD1063938
Entities
People
- Benjamin Renquist
Organizations
- University of Alabama